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Abstract
Regenerative medicine and tissue engineering therapies present an attractive treatment
alternative to the current traditional clinical treatments. Stem cells are capable of self-
renewal and multilineage differentiation. They also have the ability to create immuno-
modulatory microenvironment, and thus help to minimize organ damage caused by the
inflammation and cells activated by the immune system. Human bone marrow mesen-
chymal stem/stromal cells (MSCs) have great potential for cellular therapy, as they possess
the abilities to proliferate as well as to differentiate. MSCs are present in all tissues
interacting with tissue cells and easy to isolate and expand in culture. Indeed, histological
examination of MSCs is one of the main goals for studying their morphology. Both the
light and the electron microscopes are essential tools where the histologist can identify the
structure as well as the detailed ultrastructure of these cells. This will guide users to
clearly understand their behavior, both in vivo and in vitro. Thus, the aim of this chapter
is to give a spot of light on these cells and their histology.
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1. Introduction
Stem cells can be defined as undifferentiated cells that have the ability to self-renewal; prolif-
erate into undifferentiated cells, and to differentiate into various mature specialized cells [1].
There are different types of stem cells that have been classified according to their potency. Cells
are described as pluripotent that is, embryonic cells from the blastocyst (4–14 days after oocyte
fertilization), they can differentiate into all cell types of the adult organism. If, in addition, they
can form the extraembryonic tissues of the embryo, they are described as totipotent (1–3 days
from oocyte fertilization) which can give rise to all the embryonic tissues and placenta.
Multipotent stem cells that is, embryonic cells from the 14th day onward, have the ability to
form all the differentiated cell types of a given tissue. The stem cells that maintain only one
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lineage are described as unipotent [2]. In the trilaminar embryo, a middle mesodermal layer is
formed between the ectodermal and endodermal cell layer. This mesodermal cell layer con-
tains mesenchymal stem cells (MSCs), which develop into connective tissue (mesenchyme) and
it maintains the progenitor stem cells that persist after birth [3].
2. Sources of stem cell
2.1. Embryonic stem cells
Embryonic stem cells (ESCs) have the greatest potential to differentiate into all cell types. ESCs
are derived from the inner cell mass of the blastocysts. However, the use of ESC is associated
with several ethical issues [4]. Also, safety concerns were raised with a high incidence of
teratoma formation [5].
2.2. Induced pluripotent stem cells
Induced pluripotent stem cells (iPS) were first achieved by inducing a forced expression of
specific genes that can reprogram human andmouse adult somatic cells into the undifferentiated
cell [6, 7]. iPS have the same characteristics of ESCs, such as expression of pluripotency markers
and differentiation capability [6].
2.3. Fetal stem cells
Fetal stem cells (FSCs) are derived either from a fetus or from extraembryonic structures. Various
subtypes of FSCs were described according to their origin (i.e., amniotic fluid, umbilical cord,
Wharton’s jelly, amniotic membrane, and placenta). FSCs are ideal sources of cells for use in
regenerative medicine. They are easily accessible, having a high proliferation rate. In addition,
FSCs do not form teratomas [8] and overcome the ethical problem associated with ESCs [9].
2.4. Adult stem cells
In principle, adult stem cells are unspecialized (undifferentiated) cells. They are found in differ-
entiated tissues and considered to be quiescent, but still capable of self-renewal and differentia-
tion. These cells remain in their undifferentiated state until stimulated [10]. Adult MSCs have
been isolated from different sites: bonemarrow, adult peripheral blood, tooth pulp and liver [11].
3. Mesenchymal stem/stromal cells (MSCs)
3.1. History
The concept of mesenchymal stem/stromal cells (MSCs) was first introduced about half a century
ago. In the 1970s, [12] Alexander Friedenstein described a population of bone marrow-derived
cells of mesodermal origin. These MSCs were shown to have the ability to self-renew and to
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differentiate into a multitude of mesodermal cell types [13–15]. Bone marrow MSCs represent a
heterogeneous population derived from the nonblood-forming fraction of bonemarrow, but have
the ability to regulate hematopoietic cell development. In vitro, adult mesenchymal stem cells
resident in this bone marrow fraction differentiate into bone, cartilage and fat [16]. Recently, a
standardized nomenclature for MSCs has been proposed and the term “multipotent mesenchy-
mal stromal cells” has been introduced [15] to refer to this population of fibroblast-like, plastic-
adherent cells [17]. Their asymmetric division produces one identical daughter stem cell and a
second progenitor cell that becomes committed to a lineage-specific differentiation program [18].
3.2. Importance and uses
MSCs produce many growth factors and essential cytokines needed for cell proliferation and
differentiation [19]. They also support hematopoiesis in bone marrow and play an indirect role
in supporting other cell types during tissue repair [20]. Adult stem cells could overcome many
of the ethical and technical debate associated with ESC as they are isolated from adult tissues,
including bone marrow stromal cells, adipose-derived stem cells and adult skin stromal cells
[21]. However, because of their limited differentiation potential (multipotent), they are less
likely to form tumors, although some are thought to be related to certain tumors [22].
3.3. Location
The exact location of these cells in vivo is not known, but recent work suggests that MSCs are
located in the perivascular spaces as sub-endothelial cells surrounding the vascular sinusoids
in the bone marrow [23]. Bone marrow contains three main cell types: endothelial cells,
hematopoietic stem cells, and stromal cells. Bone marrow connective tissue network is called
the stroma. The stroma consists of a heterogeneous population of cells that provide structural
and physiological microenvironment to support hematopoietic cells and forms a complex
extracellular matrix, which supports the hematopoietic process [23]. However, the frequency
of MSCs in human BM has been estimated to be in the range of 0.001–0.01% of the total
nucleated cells. Furthermore, the frequency of MSCs declines with age, from 1/104 nucleated
marrow cells in a newborn to about 1/106 nucleated marrow cells in an 80-year-old person [24].
4. Biology of stromal cells/MSCs
4.1. Tissue distribution
Interestingly, MSCs reside in diverse tissues throughout the adult organism [25]. Nowadays,
MSC populations have been obtained from many tissues other than the bone marrow, [26]
including the adipose tissue [27] and placenta [28].
4.2. Properties
Mesenchymal/stromal cells (MSCs) have the ability to differentiate into a variety of different
cells/tissue lineages; osteoblasts, chondroblasts, adipoblasts and reticular stromal cells [29].
Stromal Cell Ultrastructure
http://dx.doi.org/10.5772/intechopen.76870
29
MSCs possess potent immunomodulatory and anti-inflammatory effects and have been used
as agents in autoimmune diseases [30]. They interfere with pathways of the immune response
by means of direct cell-to-cell interactions and soluble factor secretion. In vitro, MSCs inhibit
proliferation of T cells, B-cells, natural killer cells and dendritic cells [31].
4.3. Immunobiology
MSCs are believed to have critical roles in repairing damaged tissues. Tissue injury is associ-
ated with the activation of immune/inflammatory cells. In addition, inflammatory mediators,
chemokines and leukotrienes, are often produced in the microenvironment by phagocytes in
response to damaged cells [32]. Nevertheless, the function of the endothelial cells as a barrier is
often broken down in damaged tissues. Thus, these inflammatory molecules and immune
cells, together with endothelial cells and fibroblasts, result in the mobilization and differentia-
tion of MSCs and replace the damaged tissue cells. The study of endogenous MSC migration is
complex. Once MSCs have entered the microenvironment of injured tissues, MSCs start releas-
ing many growth factors, including epidermal growth factor (tissue regeneration), fibroblast
growth factor (cell survival and regeneration), platelet-derived growth factor (tissue repair),
vascular endothelial growth factor (angiogenesis and wound healing), hepatocyte growth factor
(intrinsic neural cell regeneration), angiopoietin-1 (angiogenesis) and stromal cell-derived factor-1
(neuroprotective effect). These growth factors, in turn, promote the development of fibroblasts,
endothelial cells and tissue progenitor cells, which carry out tissue regeneration and repair [33].
4.4. Homing
Studies have shown that MSCs have the ability to migrate and to home to a variety of tissues.
The migration process is represented by several distinctive steps and starts with the resistance
and adhesive interactions between cells flowing through the bloodstream and vascular endo-
thelium. The mechanisms used are assumed to follow the same steps that were described for
leukocyte homing.
In the first step, the cells come into contact with the endothelium by tethering and rolling.
Different molecules are involved in such process. The selectins on the endothelium are
primarily involved and the expression of hematopoietic cell E/L-selectin ligand which is a
specialized form of cluster of differentiations (CD), CD44. This step is mediated by the
homing receptors expressed on circulating cells which interact with their corresponding
receptors expressed on the layer of endothelial cells. [34]. As regards the second step, the
cells are activated by G-protein-coupled receptors, followed by integrin-mediated activation.
MSCs express various integrins on their surface, among which integrin α4/β1, which medi-
ates cell–cell and cell- extracellular matrix interactions by binding to vascular cell adhesion
molecule 1 and to the V-region of fibronectin, respectively. In damaged tissues, fibronectin
is deposed together with fibrin at the injured site to stop the bleeding. The provisional matrix
is then remodeled by macrophages and fibroblasts, determining an increase in V region-
exposing fibronectin, which, in turn, allows MSCs to adhere and transmigrate into the
extracellular matrix. In the last step, diapedesis or transmigration occur through the endo-
thelium as well as through the underlying basement membrane. In this step one of the
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matrix metalloproteinases (MMP) - which are lytic enzymes required to cleave the compo-
nents of the basement membrane - the gelatinases MMP-2 and MMP-9 are the most impor-
tant because they specifically degrade collagen and gelatin components of the basement
membrane [35].
4.5. Characterization
MSCs isolated directly from bone marrow are positive for CD44. They are also positive for
CD29, CD73, CD90, CD105 and CD166. On the other hand, they are negative for the
hematopoietic surface markers such as CD11b, CD45, CD31, CD106, CD117 and CD135
[36]. As progress in phenotyping the MSCs and its progeny continues, the use of selective
markers has resulted in the enhanced propagation and enrichment of the MSC population,
while maintaining them in an undifferentiated state without diminishing the differentiation
potential [37].
A part of a work [38] was carried out at Department of Trauma, Hand and Reconstructive
Surgery, Johann-Wolfgang-Goethe University Hospital, Frankfurt, Germany. They demon-
strated that MSCs expressed typical MSCs specific antigens CD73, CD90 and CD105 (hemato-
poietic surface marker) and were negative for the hematopoietic marker and lymphocytic
markers CD34, CD45, respectively. According to the International Society of Cell Therapy,
CD73, CD90 alongside CD105 are positively expressed on MSCs and remain the primary
molecules used to identify MSCs [39]. The phenotypic characterization of MSCs from bone
marrow has been further realized through the identification of the cytokine expression profile
of undifferentiated cells. Constitutive expression of cytokines, such as granulocyte-colony
stimulating factor, stem cell factor, leukemia inhibitory factor, macrophage-colony stimulating
factor, and IL-6 and IL-11 is consistent with the ability of MSCs to support hematopoiesis [40].
5. Culturing
In order to avoid patient morbidity, the amount of MSCs that could be isolated from BM
aspirate should be too small [12]. Therefore, they should be cultured in vitro to enable the
expansion of MSCs to generate millions of cells which can be used for further therapeutic
applications [39]. It was stated that MSCs retain more potential to differentiate after the third
passage (P) [41]. In addition, over 70% of clinical trials used MSCs from 1 to 5 passages [42].
Moreover, a study reported that MSCs from 7 to 9 passages underwent osteogenic differentiation
more than cells of later passages. Moreover, recent data indicated that reactive oxygen species-
handling mechanisms (i.e., antioxidative activity/reduction potential) become disrupted in later
passages, a condition, which was not observed in the lower passage [43].
Although several researchers [41] showed that with the long-term expansion of MSCs and
with several sub-culturing, the cells lose their differentiating ability, a study performed [44]
reported that no change at the level of genetic expression or differentiation capability of long-
term cultured MSCs. Furthermore, MSCs have a stable phenotype over many generations
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in vitro [45]. Another study [46] reported that MSCs retained their multilineage differentiation
potential till passage 10 (P10) and maintain high levels of telomerase activity and long telo-
mere length up to P10, but steady decline in the efficiency of proliferation in all cell
populations after P10. Furthermore, MSCs showed a marked increase in the time required for
cell doubling and showed an enlarged, flattened cellular morphology at P15, after which they
ceased to undergo cell division but remained viable in culture. Thus, cells from passage 9 were
used for differentiation as it was needed to obtain sufficient cell numbers for use through
extensive cell quantity amplification and later passages were avoided [47].
6. Histology
Studying the behavior of MSCs in vitro has become an urgent need to give more insights on
their behavior in vivo and their mechanisms in initiating osteogenesis. Indeed, histological
examination of MSCs is one of the main goals for studying their morphology in vitro by light
microscope. Although it is a primary step, yet, it is not sufficient to rely on it alone, to detect
their behavior during their differentiation process, and as such it has to be accompanied by
ultrastructure examination to correlate between their morphology and behavior.
6.1. Light microscope
MSCs are characterized by being star-shaped cell with thin long processes [48]. Using hema-
toxylin and eosin stains, MSCs are characterized by pale cytoplasm, large vesicular nucleus
and multiple thin processes (Figure 1).
6.2. Phase contrast microscope
Regardless of the issue of origin, all MSCs share characteristics by consensus definition: they
are spindle-shaped and plastic-adherent. In our study, [38] isolated human bone barrow MSCs
Figure 1. Light microscopic picture of the umbilical cord showing MSCs with many thin processes (arrow). Each cell
exhibits a vesicular nucleus. Scale bar 50 μm.
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revealed that the cells were adherent to the surface of tissue culture plastic flask. Furthermore,
the cells were spindle in shape; which is considered as a second important characteristic of
mesenchymal cell morphology. Researchers [38] described a population of adherent cells in
culture till P5 (Figure 2). Most of the cells exhibited fibroblast-like spindle shape and showed
vesicular nuclei with prominent nucleoli. Moreover, in P9, the adherent cells remained
attached to the surface with their characteristic spindle shape (Figure 3). The cells exhibited
vesicular nucleus, prominent nucleolus and multiple processes [38].
6.3. Electron microscope
6.3.1. Scanning electron microscope (SEM)
The two-dimensional morphology of MSCs demonstrated by scanning electron microscope
(SEM) [38] showed the spindle-shaped cells with eccentric nuclei and several thin cytoplasmic
processes extending from the edge of the cell surface in P5 and P9. In addition, cells in P 9
maintained their spindle shape (Figure 4). These SEM results were also reported [49].
Figure 2. Cultured human bone marrow derived stromal cell from passage 5, showing adherent cells with their charac-
teristic spindle shape (arrow) [38]. Scale bar 200 μm.
Figure 3. Cultured human bone marrow derived stromal cell from passage 9, showing adherent cells with their charac-
teristic spindle shape (arrow) [38]. Scale bar 200 μm.
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6.3.2. Transmission electron microscope (TEM)
Electron microscopic examination of MSCs in culture revealed the presence of euchromatic
nucleus associated with abundant cell organelles which are considered as an indicator of an
active cell (Figure 5). The spindle-shaped cells showed large irregular, euchromatic nucleus
and the peripheral heterochromatin was slightly condensed along the inner surface of the
nuclear membrane and nuclear pores (Figure 6). The cytoplasm showed many elongated pro-
files of rough endoplasmic reticulum and multiple mitochondria (Figure 7). Cytoskeletal
structures were seen as fine filaments running parallel to the long axis of the cell near the
nuclear membrane as well as beneath the cell membrane (Figure 6).
The same features of active MSCs were noticed after 14 days in culture. The cells exhibited a
large euchromatic nucleus with numerous profiles of rough endoplasmic reticulum and mul-
tiple rounded mitochondria. In addition, the cell surface showed thin pseudopodia (Figure 7).
Cytoskeletal filaments were irregularly dispersed in the cytoplasm as well as around the
nucleus (Figure 7). Such observation was explained by the fact that the intracellular organelles
architecture is organized by the cytoskeleton [36, 50, 51].
Figure 4. Cultured human bone marrow derived stromal cell, showing spindle shape cell with an eccentric nucleus (N)
and multiple processes (P) [38]. Scale bar 50 μm.
Figure 5. Transmission electron micrograph of cultured human bone marrow derived stromal cell on day 7. The cell is
spindle in shape with an euchromatic nucleus (N). The cytoplasm shows mitochondria (M) and multiple lysosomes (L)
[38]. Scale bar 1 μm.
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Moreover, after 21 days in culture, the cells showed clearly demarcated nucleolus (Figure 8). In
addition, numerous large macro vesicles associated with the mature face of the Golgi complex
were clearly depicted (Figure 9). These cells are now ready for differentiation once in the
appropriate media. The structure of these cells would differ during the process of differentia-
tion accordingly.
Another ultrastructure feature of MSCs is the presence of vesicles in the cytoplasm.
Intercellular communication can be mediated through direct cell–cell contact or transfer of
secreted molecules. Recently, a third mechanism has emerged that involves intercellular trans-
fer of extracellular vesicles. Cells release into the extracellular environment membrane vesicles
either of endosomal origin or of plasma membrane origin. They are named exosomes and
microvesicles, respectively [52]. In the study [38] carried out on isolated MSCs, showed vesic-
ular trafficking. (Figure 10) These vesicles were prominent after the cells were cultured in a
Figure 6. Transmission electron micrograph of cultured human bone marrow derived stromal cell showing part of the
same cell exhibiting an euchromatic nucleus (N) with nuclear pores (arrow heads). The peripheral heterochromatin (H) is
seen along the inner aspect of the nuclear membrane. Fine cytoskeletal filaments are noticed parallel to the long axis of the
cell near the nuclear and cell membranes (arrows) [38]. Scale bar 0.5 μm.
Figure 7. Transmission electron micrograph of cultured human bone marrow derived stromal cell on day 14. The
cytoplasm exhibits numerous profiles of rER, mitochondria (M), and well-developed Golgi complex (G). The cell mem-
brane exhibits a pseudopodium (Pd). Cytoskeletal filaments are irregularly dispersed in the cytoplasm (arrows). Part of
an euchromatic nucleus is also seen (N) [38]. Scale bar 0.5 μm.
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Figure 8. Transmission electron micrograph of cultured human bone marrow derived stromal cells on day 21, showing
large euchromatic nucleus (N) with clearly demarcated nucleolus (n). The cytoplasm shows mitochondria (M) [38]. Scale
bar 1 μm.
Figure 9. Transmission electron micrograph of cultured human bone marrow derived stromal cells on day 21, showing
part of its cytoplasm with multiple well-developed Golgi complexes (G) associated with large secretory vesicles (V),
numerous mitochondria (M), and lysosomes (L). The cytoplasm shows profiles of rough endoplasmic reticulum (rER)
[38]. Scale bar 0.5 μm.
Figure 10. Transmission electron micrograph of cultured human bone marrow derived stromal cells. The cytoplasm
shows several cytoplasmic vesicles (Vs) of variable sizes. A coated pit (arrowhead) and numerous subplasmalemmal
vesicles are also seen (thick arrows). A surface pseudopodium (Pd) is seen [38]. Scale bar 0.5 μm.
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media that stimulated its osteogenic differentiation. Microvesicles vary in size and are formed
by the budding of the plasma membrane. Most cell types are known to produce microvesicles
either constitutively or when stimulated during apoptosis or activation. The mechanisms
involved in the mobilization of secretory microvesicles to the cell periphery, their docking,
and fusion with the cell surface require the cytoskeleton (actin and microtubules), associated
molecular motor proteins (kinesins and myosins) as well as other factors [53, 54]. The other
clearly defined class of secreted membrane vesicles that originate from the endosomes are the
exosomes. Exosomes were first discovered by Pan and Johnstone in 1983 [55]. They are formed
by the invagination of endolysosomal vesicles to form multi-vesicular bodies. Exosomes are
released by exocytosis. First, the cell membrane is internalized to produce endosomes. Subse-
quently, many small vesicles are formed inside the endosome by invaginating parts of the
endosome membranes. Such endosomes are called MVBs. Finally, the MVBs fuse with the cell
membrane and release the intraluminal endosomal vesicles into the extracellular space to
become exosomes [56].
Exosomes directly interact with the signaling receptors of target cells [57]. After that, the
exosomes fuse with the plasma membrane of recipient cells and deliver their content into
the cytoplasm [58]. Finally, the exosomes are internalized into the recipient cells. Once in the
recipient cell, some of these engulfed exosomes may merge into endosomes and move
across the recipient cells to be released into the neighboring cells. In the other case,
endosomes fused from engulfed exosomes will mature into lysosomes and undergo degra-
dation [57, 59].
Lipids and proteins are the main components. The protein content of exosomes from different
cell types contains different endosome-associated proteins (e.g., RabGTPase, SNAREs, Annexins
and flotillin). They are also enriched in proteins that associate with lipid rafts, including
glycosylphosphatidylinositol-anchored proteins and flotillin [60]. The other main component of
exosomes is the lipid. In comparison to the plasma membrane, exosomes are highly enriched in
cholesterol, sphingomyelin and ceramides at the expense of phosphatidylcholine and phospha-
tidylethanolamine [52]. In addition to the proteins and lipids, various nucleic acids have recently
been identified in the exosomal lumen, including mRNAs, microRNAs and other noncoding
RNAs [61].
The main functions of exosomes are their capacity to act as antigen-presenting vesicles, to
stimulate immune responses [62]. Another main important feature of exosomes is being an
ideal drug delivery vehicle. Meanwhile, research has been carried out encapsulating anticancer
drugs into exosomes [63].
The function of MSC-derived exosomes has not been well defined. They act as an intercellular
communication vehicle for modulating cellular processes. It was recently revealed that
exosomes derived from MSCs play important roles in mediating the biological functions of
MSCs [64].
A study demonstrated the electron microscopy of exosomes. They were cup-shaped and
measured 40–100 nm in diameter. Exosomes are naturally secreted and well tolerated by the
body. They are also safely stored and provide many therapeutic applications with avoiding the
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risk of immunological rejection and malignant transformation [65]. Therefore, the use of MSCs
to produce exosomes for drug delivery is the subject of the day [66]. Recently, liposomes are
preferred drug delivery systems. It is a synthetic vesicle with a phospholipid membrane that
has the ability to self-assemble into various sizes and shapes in an aqueous environment [67].
Another morphological feature detected is pseudopodia-like structures extending from the cell
membrane (Figures 7 and 10). This might explain the capacity of the cells for migration within
the receiving tissue. The main role of these structures is to transmit the produced material from
one cell into another by extending the pseudopodia and communicating cells with each other
as well as in cell signaling [68]. Interestingly, one of the most striking features during differen-
tiation is the observation of finger-like extensions of the plasma membrane known as
fibripositors (Figure 11). These fibripositors were located at the side of the cell and protrude
into the spaces between cells. These fibripositors are the site where collagen fibrils were
located. It was reported that the initial stage of extracellular matrix deposition results in arrays
of short collagen fibrils completely enclosed within these fibripositors. These fibrils are then
subsequently deposited extracellularly [69, 70].
It was reported that fibrils leaving the fibripositors were seen to run along the external surface
of the cell. Tracking of fibrils revealed that the collagen fibrils in fibripositors were shorter than
those extracellularly. Thus, these data suggested that fibripositors might be a place of fibril
assembly. They determined that short fibrils become longer inside closed fibripositors, then
protruding fibripositors (open), often project into the matrix, releasing fibrils extracellularly
where individual fibrils then coalesce into bundles. Thus, fibripositors are specialized sites not
only of fibril assembly, but also share in fibril transport extracellularly [71].
Another study declared that the fibripositors are dynamic structures and their formation and
stabilization depend on the actin cytoskeleton [72]. This might explain the existence of the
cytoskeletal filaments in the differentiating cells [38]. Accordingly, these cytoskeletal structures
might be actin filaments. It is possible that fibripositors have been involved in the alignment of
extracellular collagen fibrils in a parallel arrangement [73].
Figure 11. Transmission electron micrograph of cultured human bone marrow derived stromal cells. The cell surface of
shows an open fibripositors (short arrow) with large amounts of secretory product (S) is observed. Note the euchromatic
nucleus (N) [38]. Scale bar 0.5 μm.
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7. Conclusion
The MSCs maintained their undifferentiated histological structure till passage 9 for further
tissue engineering. A detailed histological examination using the light and the electron micro-
scopes is essential to understand the function of MSCs. In addition, exosomes represent a
promising candidate for drug delivery vehicle.
Abbreviations
ESCs embryonic stem cells
iPS induced pluripotent stem cells
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CD cluster of differentiation
MMP metalloproteinases
P passage
SEM scanning electron microscope
TEM transmission electron microscope
SNARE soluble N-ethylmaleimide-sensitive factor receptor
Rab Ras-related proteins in brain
GTP guanosine triphosphate
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